Logo Université Laval Logo Université Laval
International Chair on Cardiometabolic Risk
My Healthy Waist

Documentation centre

2053-2064 of 2541 results
Page 172 of 212
Key Publications October 25, 2016

Implications of total to high-density lipoprotein cholesterol ratio discordance with alternative lipid parameters for coronary atheroma progression and cardiovascular events.

Am J Cardiol. 2016;118:647-55

Elshazly MB, Nicholls SJ, Nissen SE, St John J, Martin SS, Jones SR, Quispe R, Stegman B, Kapadia SR, Tuzcu EM, Puri R
Cardiovascular Disease Epidemiology Lipids/Lipoproteins
Key Publications October 21, 2016

Relationship of baseline HDL subclasses, small dense LDL and LDL triglyceride to cardiovascular events in the AIM-HIGH clinical trial.

Atherosclerosis. 2016;251:454-9

Albers JJ, Slee A, Fleg JL, O'Brien KD, Marcovina SM
Cardiovascular Disease Clinical Trials Lipids/Lipoproteins
Key Publications October 21, 2016

Combined effects of exercise capacity and coronary atherosclerotic burden on all-cause mortality in asymptomatic Koreans.

Atherosclerosis. 2016;251:396-403

Choi SY, Sung J, Park HE, Han D, Chang HJ
Cardiovascular Disease Ethnicity Physical Activity/Exercise
Key Publications October 21, 2016

Polyunsaturated fats, carbohydrates and carotid disease: The Atherosclerosis Risk in Communities (ARIC) Carotid MRI study.

Atherosclerosis. 2016;251:361-6

Dearborn JL, Qiao Y, Guallar E, Steffen LM, Gottesman RF, Zhang Y, Wasserman BA
Cardiovascular Disease Lipids/Lipoproteins Nutrition
Key Publications October 20, 2016

Small and medium sized HDL particles are protectively associated with coronary calcification in a cross-sectional population-based sample.

Atherosclerosis. 2016;251:124-31

Ditah C, Otvos J, Nassar H, Shaham D, Sinnreich R, Kark JD
Cardiovascular Disease Ethnicity Lipids/Lipoproteins
Key Publications October 20, 2016

Impact of adipose tissue composition on cardiovascular risk assessment in patients with stable coronary artery disease.

Atherosclerosis. 2016;251:206-12

Kunimura A, Ishii H, Uetani T, Harada K, Hirayama K, Harata S, Shibata Y, Kawashima K, Shimbo Y, Takayama Y, Tatami Y, Kawamiya T, Osugi N, Ota T, Yamamoto D, Okumura N, Suzuki S, Amano T, Murohara T
Abdominal Obesity/Body Fat Distribution Adipose Tissue Cardiovascular Disease
Key Publications October 20, 2016

Where to now in cardiovascular disease prevention.

Atherosclerosis. 2016;251:483-9

Najam O, Ray KK
Cardiometabolic Risk Cardiovascular Disease Lipids/Lipoproteins
Key Publications October 19, 2016

Sick populations and sick subpopulations: reducing disparities in cardiovascular disease between Blacks and Whites in the United States.

Circulation. 2016;134:472-85

Lu Y, Ezzati M, Rimm EB, Hajifathalian K, Ueda P, Danaei G
Cardiovascular Disease Ethnicity Prevention
Key Publications October 18, 2016

Emerging cardiovascular disease biomarkers and incident diabetes mellitus risk in statin-treated patients with coronary artery disease (from the Treating to New Targets [TNT] study).

Am J Cardiol. 2016;118:494-8

Arsenault BJ, Kohli P, Lambert G, DeMicco DA, Laskey R, Messig MM, Kastelein JJ, Waters DD
Cardiovascular Disease Diabetes Lipids/Lipoproteins
Key Publications October 17, 2016

Potatoes and risk of obesity, type 2 diabetes, and cardiovascular disease in apparently healthy adults: a systematic review of clinical intervention and observational studies.

Am J Clin Nutr. 2016;104:489-98

Borch D, Juul-Hindsgaul N, Veller M, Astrup A, Jaskolowski J, Raben A
Cardiovascular Disease Diabetes Nutrition
Key Publications October 14, 2016

Achieving the WHO sodium target: estimation of reductions required in the sodium content of packaged foods and other sources of dietary sodium.

Am J Clin Nutr. 2016;104:470-9

Eyles H, Shields E, Webster J, Ni Mhurchu C
Cardiovascular Disease Hypertension Nutrition
Expert Opinions October 12, 2016

What key progresses in cardiovascular medicine were made over the last 50 years?

Philip J. Barter, MD, MBBS, FRACP, PhD, Conjoint Professor, University of New South Wales, Sydney, Australia
Cardiometabolic Risk Cardiovascular Disease Prevention
of 212